CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns [Phase 2]
Summary
Phase 2 feasibility study evaluating enzymatic debridement for partial thickness burns has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: MediWound Ltd | Conditions: Burn | Phase 2 | Status: COMPLETED